M3 Advisory Group LLC Acquires 135 Shares of Colgate-Palmolive Company (NYSE:CL)

M3 Advisory Group LLC lifted its holdings in Colgate-Palmolive Company (NYSE:CLFree Report) by 4.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,310 shares of the company’s stock after purchasing an additional 135 shares during the period. M3 Advisory Group LLC’s holdings in Colgate-Palmolive were worth $310,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC acquired a new position in Colgate-Palmolive during the fourth quarter valued at approximately $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at $27,000. Vermillion Wealth Management Inc. bought a new position in Colgate-Palmolive in the 4th quarter worth $31,000. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive during the 4th quarter worth $32,000. Finally, Briaud Financial Planning Inc bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $32,000. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CL has been the topic of a number of recent analyst reports. UBS Group lifted their price objective on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a “buy” rating in a research note on Thursday, April 17th. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an “overweight” rating in a report on Monday, April 28th. Wells Fargo & Company raised their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “underweight” rating in a research note on Wednesday, April 2nd. Barclays cut their target price on shares of Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating for the company in a research note on Friday, April 11th. Finally, Wall Street Zen lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus price target of $102.12.

Check Out Our Latest Stock Analysis on CL

Colgate-Palmolive Trading Down 0.4%

Shares of CL opened at $87.85 on Monday. The stock has a 50 day simple moving average of $91.50 and a 200-day simple moving average of $90.75. The company has a current ratio of 0.85, a quick ratio of 0.54 and a debt-to-equity ratio of 8.96. The stock has a market cap of $71.19 billion, a PE ratio of 24.82, a PEG ratio of 4.66 and a beta of 0.38. Colgate-Palmolive Company has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same period last year, the business earned $0.86 earnings per share. The business’s revenue was down 3.0% on a year-over-year basis. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.37%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.76%.

Colgate-Palmolive declared that its board has initiated a share repurchase plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to reacquire up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s management believes its stock is undervalued.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.